how to dilute 10 mg tirzepatide 2023 Lecture: Dr. Heidi Diez, PharmD, MCT2D Co-Director Semaglutide & Tirzepatide Dosing Guide:

Most patients qualify with either: A BMI of 30 or higher, or A BMI of 27+ with a weight-related condition (high blood pressure, type 2 diabetes, high cholesterol) At your consult, Josh reviews your history, medications, and goals to decide whether GLP-1 treatment is clinically appropriate for you

Nausea Diarrhea Decreased appetite Vomiting Constipation Dyspepsia (indigestion) Abdominal pain Injection-site reactions Fatigue Pancreatitis Gallbladder disease (cholelithiasis, cholecystitis) Acute kidney injury (usually from dehydration via GI fluid loss) Hypoglycemia (mainly when combined with insulin or a sulfonylurea) Diabetic retinopathy complications Hypersensitivity reactions Thyroid C-cell tumours (boxed warning

In patients with comorbid coronary artery disease, obesity, and diabetes, GLP-1 agonists and SGLT-2 inhibitors should be used as first-line agents, over metformin

muscle and fat tissues) and the lowered hepatic insulin extraction (46)

It is a groundbreaking medication thats transforming how people manage their weight